Orchid Pharma Limited — Others, 30-12-2024: Trading Window

Orchid Pharma Limited has announced a board meeting to review its financial results for the quarter and half-year ending December 31, 2024. The trading window for securities will be closed from January 1, 2025, until 48 hours after the financial results are declared, preventing insiders from trading during this period. This closure signifies the company's adherence to insider trading regulations, protecting sensitive financial data. Investors might view this as a standard operational procedure, with a neutral impact on sentiment as the focus remains on upcoming financial disclosures.